From the Sector

Reset
242 results
Graphic Euratex
16.12.2022

European textiles industry extremely concerned about the fast loss of competitiveness

  • Potential loss of competitiveness, caused by the EU’s inaction of the energy crisis, and Chinese and US subsidies to domestic industry

Following yesterday’s European Council summit and its conclusions on the measures to tackle the energy crisis, the European textiles industry is extremely concerned about the fast loss of competitiveness of Europe and demands urgent action to save the industry.

The chain of factors determining this sharp decline in competitiveness is twofold. First, the energy cost in Europe is more than 6 times higher than in the US, China, and neighbouring countries. This factor alone has almost erased the business case for producing in the EU. At present, many textiles and clothing companies are producing at net loss or have shut down production. The industrial conditions have worsened in such a way that there is no business case to invest in Europe or buy products produced or processed in the EU. It is only the sense of responsibility of the entrepreneurs towards the European society that is keeping the plants and production running.

  • Potential loss of competitiveness, caused by the EU’s inaction of the energy crisis, and Chinese and US subsidies to domestic industry

Following yesterday’s European Council summit and its conclusions on the measures to tackle the energy crisis, the European textiles industry is extremely concerned about the fast loss of competitiveness of Europe and demands urgent action to save the industry.

The chain of factors determining this sharp decline in competitiveness is twofold. First, the energy cost in Europe is more than 6 times higher than in the US, China, and neighbouring countries. This factor alone has almost erased the business case for producing in the EU. At present, many textiles and clothing companies are producing at net loss or have shut down production. The industrial conditions have worsened in such a way that there is no business case to invest in Europe or buy products produced or processed in the EU. It is only the sense of responsibility of the entrepreneurs towards the European society that is keeping the plants and production running.

Secondly, while the EU is passive and extremely slow in articulating a credible and effective response to the energy crisis, the main international competitors and trade partners (China, India and the US respectively) have developed comprehensive state-aid frameworks for their domestic industry despite not being affected by this crisis at all. The latest example is the 369-billion-dollar scheme of the Inflation Reduction Act rolled out by the Biden administration.

Recent trade data  already indicate a loss of global competitiveness: imports to the EU have grown tremendously in 2022 (+35% year-to-date). It is also evident that the surge in imports goes in parallel with the surge of natural gas price. It is expected that energy prices will remain high and volatile, opening the door for imports to gain substantial market shares in the EU.

The chart indicates the development of the Title Transfer Facility (TTF) until September 2022 since Eurostat data for Q4 2022 has not been published yet. Euratex is aware that the market situation has eased somewhat since in the past months, but the crisis remains because gas prices are still extremely high in comparison to last year. This suggests that the current loss of competitiveness of the EU manufacturing will not be recovered even with lower energy prices, unless measures are taken to correct the unlevel playing field on which the EU industry has to operate in the international markets. Only with an ambitious and comprehensive relaunch plan at EU level, Europe will be able to restore its credibility as a global manufacturing powerhouse and investments.

If the status quo is maintained, not only the EU will not be able to recover its competitive position on the global business stage, but it will also fail its plans to reach zero-net emissions and achieve circularity. It is evident that these ambitions - that the industry is passionately supporting - need massive capital investments. However, in the current scenario an investments diversion can only be expected to markets where governments are actively supporting those investments and energy costs are much lower – regardless of their fossil- or non-fossil origin.

The European textiles industry – the whole value chain, from fibres, nonwoven, to fabrics, clothing manufacturers - are facing unprecedented pressure deriving from the current geopolitical situation, the new macroeconomic conditions and unfair competition from third states. The situation is going to worsen if no emergency action is taken, especially because a recession is expected in the coming months.

The main structural component of the EU manufacturing are SMEs: these are economic actors that are particularly exposed to the current crisis as they do not have the financial leverage to absorb the impact of energy prices for much longer. Urgent EU action is needed to ensure their survival.

EURATEX calls on the EU political leaders in the Commission, in the European Council and in the national capitals to:

  1. Raise the ambition and adopt a comprehensive approach at EU level: energy, state-aid and trade policy must be brought together in a single strategy with concrete emergency solutions and with a clear SME dimension;
     
  2. Let all hesitations aside and adopt a meaningful price cap on natural gas wholesales, that should be ideally no higher than 80 euro/MWh. In parallel, it should also be ensured that electricity prices are brought to a sustainable price level;
     
  3. Change the European posture on state-aid, even temporarily. An ambitious plan of investments and state-aid in green technologies to support the industrial transition should be rolled out.

Such a plan, however, should not be conceived as a retaliation against our most necessary and like-minded trade partners. Access to finance and markets must be safeguarded for all those actors who are capable and willing to invest in Europe, on the basis of reciprocity. In   these challenging times for geopolitical stability, ensuring strong trade ties with our traditional allies and partners is of utmost importance. The roll-out of an investment and state aid plan should not interfere, but rather support, the dialogue with the US (and other partners) and the deepening of our trade and investment partnership. Such a dialogue should be accelerated in the context of the TTC as well as at WTO level.

Source:

Euratex

02.12.2022

Baldwin presents sustainable TexCoat G4 Finishing System at Igatex Pakistan

Baldwin Technology Company Inc. announced that Igatex Pakistan will officially kick off its new partnership with long-established Pakistan textile technology agent Al Ameen Trading Corporation. Representatives from both companies will team up to demonstrate Baldwin’s highly sustainable TexCoat™ G4 finishing system.

Igatex, the International Exhibition for Garment, Textile Machinery and Accessories, takes place December 1-4 at the Expo Centre in Lahore. Baldwin and Al Ameen will demonstrate TexCoat G4 and provide details on Baldwin’s Plasma Pure corona treatment as well as TexMoister G2™ remoistening systems technologies.

Baldwin Technology Company Inc. announced that Igatex Pakistan will officially kick off its new partnership with long-established Pakistan textile technology agent Al Ameen Trading Corporation. Representatives from both companies will team up to demonstrate Baldwin’s highly sustainable TexCoat™ G4 finishing system.

Igatex, the International Exhibition for Garment, Textile Machinery and Accessories, takes place December 1-4 at the Expo Centre in Lahore. Baldwin and Al Ameen will demonstrate TexCoat G4 and provide details on Baldwin’s Plasma Pure corona treatment as well as TexMoister G2™ remoistening systems technologies.

Baldwin’s TexCoat G4 non-contact precision-spray technology helps textile finishers up their game by enabling consistent, high-quality finishing, with zero chemistry waste and drastically minimized water and energy consumption. With Baldwin’s innovative system, the chemistry is precisely distributed across the textile surface and is applied only where it is required, on one or both sides of the fabric. The non-contact technology eliminates chemistry dilution in wet-on-wet processes, allowing full control of maintaining consistent chemistry coverage rates. Plus, pad bath contamination is eliminated, and changeovers are only required when there is a change of finish chemistry.

Source:

Baldwin Technology Company Inc.

(c) Anthropics Technology
02.12.2022

Zyler wins Grosvenor Social Shopping Experience Challenge

Grosvenor, an international retail development and investment company, has launched a search for new technologies that promote innovation and create a social customer experience. A major aim of the challenge was to drive retail recovery in a post-pandemic world where bricks and mortar stores saw footfall slump. Zyler’s try-on solution impressed the judges and the companies will launch the technology with Grosvenor’s retail tenants.

Zyler’s patented technology allows customers to see themselves in any outfit with a head and shoulders photo and basic measurements virtually. For retailers, the try-on experience can be embedded into a website or existing app with only a small snippet of code needed.

Grosvenor, an international retail development and investment company, has launched a search for new technologies that promote innovation and create a social customer experience. A major aim of the challenge was to drive retail recovery in a post-pandemic world where bricks and mortar stores saw footfall slump. Zyler’s try-on solution impressed the judges and the companies will launch the technology with Grosvenor’s retail tenants.

Zyler’s patented technology allows customers to see themselves in any outfit with a head and shoulders photo and basic measurements virtually. For retailers, the try-on experience can be embedded into a website or existing app with only a small snippet of code needed.

Source:

Anthropics Technology

(c) INDA
MaryJo Lilly, Market Intelligence Leader
30.11.2022

INDA names MaryJo Lilly as Market Intelligence Leader

INDA, the Association of the Nonwoven Fabrics Industry, has named MaryJo Lilly as its new Market Intelligence Leader. Lilly brings more than 20 years of nonwovens & engineered materials expertise with a background in the disposable, medical and specialty materials industries.

Before starting a consulting firm two years ago, Lilly was Regional Commercial Director of North America for Tredegar Film Products and before that, spent more than a decade as Vice President of Sales at Berry Global in the Health, Hygiene, and Specialties Division growing the personal care and medical markets.

Additionally, Lilly’s leadership experience includes Global Business Director at Clopay Plastic Products and Director of Sales and Marketing for Absorbent Materials at Rayonier Performance Fibers. Lilly holds a Ph.D. from the University of Pittsburgh.

INDA, the Association of the Nonwoven Fabrics Industry, has named MaryJo Lilly as its new Market Intelligence Leader. Lilly brings more than 20 years of nonwovens & engineered materials expertise with a background in the disposable, medical and specialty materials industries.

Before starting a consulting firm two years ago, Lilly was Regional Commercial Director of North America for Tredegar Film Products and before that, spent more than a decade as Vice President of Sales at Berry Global in the Health, Hygiene, and Specialties Division growing the personal care and medical markets.

Additionally, Lilly’s leadership experience includes Global Business Director at Clopay Plastic Products and Director of Sales and Marketing for Absorbent Materials at Rayonier Performance Fibers. Lilly holds a Ph.D. from the University of Pittsburgh.

With her industry knowledge and extensive network, Lilly will develop, issue and present reports, presentations and data to support INDA, member decision-making and the industry. She will, through collaboration with market participants and subject matter experts, develop and maintain relevant industry statistics, reports and surveys on the North American and worldwide markets by major segments and processing technologies.

More information:
INDA nonwovens Marketing
Source:

INDA

(c) Indorama Ventures Public Company Limited
22.11.2022

Indorama Ventures’ Deja™ brand named winner of the Best Sustainable Product Award

Indorama Ventures Public Company Limited (IVL) has been named winner of the Best Sustainable Product Award at the Chemical Week Sustainability Awards 2022. The award was for IVL’s DejaTM Carbon Neutral pellets, a carbon-neutral virgin polyethylene terephthalate (PET) resins, helping to reduce environmental impact.

The Deja™ brand covers carbon neutral virgin and recycled PET resins and a range of recycled PET (rPET) products, including flakes, resins, fibers, and yarns. It provides IVL’s global customers with a range of high-performance applications, including packaging, lifestyle, automotive, apparel, and medical equipment. The solutions help environmentally conscious companies meet their sustainability goals.

IVL has set ambitious 2025 and 2030 targets, which shall be met through its six-pronged decarbonization strategy, including energy transition, improving operational efficiency, circular feedstock, and future technologies. The company also has a goal to recycle 100 billion PET bottles annually by 2030.

Indorama Ventures Public Company Limited (IVL) has been named winner of the Best Sustainable Product Award at the Chemical Week Sustainability Awards 2022. The award was for IVL’s DejaTM Carbon Neutral pellets, a carbon-neutral virgin polyethylene terephthalate (PET) resins, helping to reduce environmental impact.

The Deja™ brand covers carbon neutral virgin and recycled PET resins and a range of recycled PET (rPET) products, including flakes, resins, fibers, and yarns. It provides IVL’s global customers with a range of high-performance applications, including packaging, lifestyle, automotive, apparel, and medical equipment. The solutions help environmentally conscious companies meet their sustainability goals.

IVL has set ambitious 2025 and 2030 targets, which shall be met through its six-pronged decarbonization strategy, including energy transition, improving operational efficiency, circular feedstock, and future technologies. The company also has a goal to recycle 100 billion PET bottles annually by 2030.

Chemical Week Sustainability Awards recognize the industry's best efforts in addressing financial, operational, and strategic challenges by focusing on ESG and sustainable product development. The awards were assessed by S&P Global, the world's leading credit rating agency, and a panel of experts from various companies across the chemical industry's value chain.

(c) Hologenix, LLC
18.11.2022

Hologenix® celebrates 20-year anniversary

Hologenix®, creators of CELLIANT®, began 20 years ago with the idea of improving the quality of people's lives and health with an emphasis on non-invasive, natural, holistic healing. Co-founder and CEO Seth Casden became fascinated with the effect infrared has on the body and worked with a dedicated team to develop and market CELLIANT® infrared technology and thus materials science innovator Hologenix came to be.

CELLIANT, a proprietary blend of IR-generating bioceramics that are ethically sourced, is a unique combination of nature and performance. CELLIANT captures and converts body heat into infrared energy for increased local circulation and cellular oxygenation, resulting in stronger performance, faster recovery and better sleep. It is a key ingredient in textiles, spanning both performance and fashion apparel, sleep and lounge wear, bedding, upholstery, uniforms and medical supplies.

Hologenix®, creators of CELLIANT®, began 20 years ago with the idea of improving the quality of people's lives and health with an emphasis on non-invasive, natural, holistic healing. Co-founder and CEO Seth Casden became fascinated with the effect infrared has on the body and worked with a dedicated team to develop and market CELLIANT® infrared technology and thus materials science innovator Hologenix came to be.

CELLIANT, a proprietary blend of IR-generating bioceramics that are ethically sourced, is a unique combination of nature and performance. CELLIANT captures and converts body heat into infrared energy for increased local circulation and cellular oxygenation, resulting in stronger performance, faster recovery and better sleep. It is a key ingredient in textiles, spanning both performance and fashion apparel, sleep and lounge wear, bedding, upholstery, uniforms and medical supplies.

The first partnership Hologenix secured was with the Ireland-based fiber company Wellman International Limited, a fully owned subsidiary of Indorama Ventures and a pioneer in recycling technologies. Hologenix still works with them today, a tribute to the company’s ability to form long-term partnerships with like-minded organizations, and their joint project of pure white CELLIANT rPET fiber was shortlisted for a prestigious Drapers Sustainable Fashion Award earlier in the year.

On the brand side, many of the first brands to incorporate CELLIANT were in the sportwear industry, including Adidas, Reebok, Saucony, Eastern Mountain Sports, Sierra Designs sleeping bags and Superfeet insoles.

In 20 years, Hologenix has achieved many scientific milestones, and CELLIANT has been and continues to be rigorously tested by a Science Advisory Board composed of experts in photobiology, nanotechnology, sleep medicine, and diabetes and wound care. The Science Advisory Board has overseen nine peer-reviewed published studies that demonstrate CELLIANT’s effectiveness and the benefits of infrared energy.

Looking ahead, Hologenix is continuing to research applications for CELLIANT in the agriculture industry and wound healing and diabetes. Expansion into the FemTech market with both product applications and scientific research about the benefits of infrared for women’s health issues is also on the horizon.

Source:

Hologenix, LLC / Sarah P. Fletcher Communications

08.11.2022

Ascend buys majority stake in recycler Circular Polymers

Ascend Performance Materials has purchased a majority stake in California-based Circular Polymers, a recycler of post-consumer, high-performance polymers including polyamide 6 and 66, polypropylene and polyester (PET). The deal provides Ascend with a consistent supply of high-quality PCR materials for its ReDefyne™ sustainable polyamides, launched at K 2022.

Circular Polymers, which as part of the deal is renamed Circular Polymers by Ascend, reclaims and processes post-consumer carpet via a unique technology and has redirected approximately 85 million pounds of waste from landfills into new goods since 2018.

“We are focused on helping our customers reach their sustainability goals and Circular Polymers by Ascend provides materials that offer strong performance with a considerably smaller environmental footprint, compared to other technologies like pyrolysis,” said Phil McDivitt, president and CEO of Ascend. “Since we launched ReDefyne, the demand for our circular products has been significant across all segments of our business, including automotive, consumer, electronics and high-performance fibers and textiles.”

Ascend Performance Materials has purchased a majority stake in California-based Circular Polymers, a recycler of post-consumer, high-performance polymers including polyamide 6 and 66, polypropylene and polyester (PET). The deal provides Ascend with a consistent supply of high-quality PCR materials for its ReDefyne™ sustainable polyamides, launched at K 2022.

Circular Polymers, which as part of the deal is renamed Circular Polymers by Ascend, reclaims and processes post-consumer carpet via a unique technology and has redirected approximately 85 million pounds of waste from landfills into new goods since 2018.

“We are focused on helping our customers reach their sustainability goals and Circular Polymers by Ascend provides materials that offer strong performance with a considerably smaller environmental footprint, compared to other technologies like pyrolysis,” said Phil McDivitt, president and CEO of Ascend. “Since we launched ReDefyne, the demand for our circular products has been significant across all segments of our business, including automotive, consumer, electronics and high-performance fibers and textiles.”

Ascend has a sustainability strategy based on three pillars: empowering people, innovating solutions and operating without compromise. Ascend has committed to reducing its greenhouse gas emissions by 80% by 2030 and recently announced two new efforts to reduce the carbon footprint of its products.

Source:

Ascend Performance Materials / EMG

(c) BVMed
03.11.2022

BVMed veröffentlicht Handreichungen zum Lieferketten-Sorgfaltspflichtengesetz

Der Bundesverband Medizintechnologie (BVMed) unterstützt die Medizintechnik-Branche bei der praktischen Umsetzung der neuen Pflichten aus dem Lieferketten-Sorgfaltspflichtengesetz (LkSG) mit einer kostenlosen Handreichung. Sie besteht aus insgesamt sechs Modulen, von denen die ersten drei Module bereits heruntergeladen werden können.

„Unser Ziel ist es, mit den Publikationen zu einem einheitlichen Branchenstandard für die Implementierung des LkSG in Medizinprodukte-Unternehmen beitragen. Damit erreichen wir Harmonisierung, Rechtssicherheit und Effizienz – und nicht zuletzt einen noch bewussteren Schutz der Menschenrechte und der Umwelt“, kommentiert BVMed-Geschäftsführer und Vorstandsmitglied Dr. Marc-Pierre Möll.

Die Module wurden vom BVMed gemeinsam mit der Kanzlei Clifford Chance und der Produktkanzlei entwickelt. Zusätzlich bietet der BVMed entsprechende LkSG-Schulungen an: Am 22. November 2022 exklusiv für seine Mitglieder sowie am 9. Dezember 2022 auch für Nicht-Mitglieder über die BVMed-Akademie.

Die kostenlose BVMed-Handreichung für Medizintechnik-Unternehmen besteht aus den folgenden sechs Modulen:

Der Bundesverband Medizintechnologie (BVMed) unterstützt die Medizintechnik-Branche bei der praktischen Umsetzung der neuen Pflichten aus dem Lieferketten-Sorgfaltspflichtengesetz (LkSG) mit einer kostenlosen Handreichung. Sie besteht aus insgesamt sechs Modulen, von denen die ersten drei Module bereits heruntergeladen werden können.

„Unser Ziel ist es, mit den Publikationen zu einem einheitlichen Branchenstandard für die Implementierung des LkSG in Medizinprodukte-Unternehmen beitragen. Damit erreichen wir Harmonisierung, Rechtssicherheit und Effizienz – und nicht zuletzt einen noch bewussteren Schutz der Menschenrechte und der Umwelt“, kommentiert BVMed-Geschäftsführer und Vorstandsmitglied Dr. Marc-Pierre Möll.

Die Module wurden vom BVMed gemeinsam mit der Kanzlei Clifford Chance und der Produktkanzlei entwickelt. Zusätzlich bietet der BVMed entsprechende LkSG-Schulungen an: Am 22. November 2022 exklusiv für seine Mitglieder sowie am 9. Dezember 2022 auch für Nicht-Mitglieder über die BVMed-Akademie.

Die kostenlose BVMed-Handreichung für Medizintechnik-Unternehmen besteht aus den folgenden sechs Modulen:

  • Modul 0: Anwendungsbereich
  • Modul 1: (Compliance-)Dokumentation
  • Modul 2: Ausgestaltung der Governance
  • Modul 3: Ausgestaltung des Beschwerdemechanismus
  • Modul 4: Risikoanalyse, -priorisierung, -prävention und -abhilfe
  • Modul 5: Jährliche Berichterstattung
Source:

BVMed | Bundesverband Medizintechnologie e.V.

31.10.2022

Cinte Techtextil China announces exhibitors for December Edition

From 7 – 9 December 2022, Cinte Techtextil China will welcome visitors sourcing solutions for 12 application areas of technical textiles and nonwovens at the National Exhibition and Convention Center in Shanghai.

A number of countries and regions are represented at the fair’s International Zone, with companies from Austria, Belgium, France, Germany, Hong Kong, Italy, the Netherlands, Spain, Sweden, Switzerland, Taiwan, and the US. Standout international exhibitors include:

From 7 – 9 December 2022, Cinte Techtextil China will welcome visitors sourcing solutions for 12 application areas of technical textiles and nonwovens at the National Exhibition and Convention Center in Shanghai.

A number of countries and regions are represented at the fair’s International Zone, with companies from Austria, Belgium, France, Germany, Hong Kong, Italy, the Netherlands, Spain, Sweden, Switzerland, Taiwan, and the US. Standout international exhibitors include:

  • TESTEX, an international, independent Swiss institute which specialises in the testing and certification of textile and leather products. The organisation is a founding member and official representative of the OEKO-TEX® Association, and will present their certification services at the fairground.
  • Cotton Council International (CCI) is a non-profit trade association that promotes US cotton fibre and manufactured cotton products, with their COTTON USA™ Mark. At this year’s fair they will showcase cotton spunlace fabric, wipes, kitchen tissues, facial masks, cosmetic removers, and more, with their products particularly applicable to Agrotech, Clothtech, Medtech, and Sporttech.
  • Graf + Cie AG is a subsidiary of the Rieter Group, and a leading supplier of clothing for carding and combs for combing machines in the short- and long-staple spinning industry. This year, the Swiss company will showcase stationary flats, and metallic card clothing for roller cards.
  • At the returning German Pavilion, buyers can source sought-after technical textiles and nonwovens that are renowned for their quality. The companies and expertise on display at this pavilion are endorsed by the Federal Republic of Germany, with several exhibitors highlighted below:
  • Brückner Textile Technologies GmbH & Co KG has developed machinery for the textile industry since 1949. Today, the company offers complete line systems for the dry finishing of both woven and knitted fabric, as well as for technical textiles, glass fibres, and floor coverings.
  • Perlon (Zhejiang) Co Ltd is part of a global group of companies that specialises in the manufacture of synthetic filaments, with factories in China, Germany, Poland, and the US. Their products have a diverse range of potential uses, largely categorised in the Agrotech and Indutech application areas.
  • IBENA Textilwerke GmbH produces various functional fabrics for Protech. At the fair, the company will be showcasing insulative, flame retardant (FR) textiles for firefighting and search & rescue services. Developed with DuPont™ aramid material, their FR properties will not diminish after washing or repeated use.

This year’s fair also sees the return of the Taiwan Zone. With support from the Taiwan Nonwoven Fabrics Industry Association, the area will showcase a range of industry leading nonwoven products and services, by brands such as KNH Enterprise, Nan Liu Enterprise, Unique Pretty Ind, and Web-Pro Corporation.

As a world’s largest manufacturer of technical textiles, China is home to a vast array of companies responsible for innovative products. Some domestic exhibitors to look out for are:

  • CTA Hi-Textiles Co Ltd, a high-tech enterprise controlled by China Textile Science Research Institute. In recent years, the company has developed several new textile composite materials, and their products are widely used in sectors such as national defence, policing and public security, medical protection, and engineering and manufacturing.
  • Sateri is one of the world’s largest producers of viscose fibre, with an annual capacity of 1.8 million metric tonnes. At their mills, they make yarn and fibre products applicable to sectors such as beauty, hygiene and personal care, medical, wipes, and protective wear.

To help international buyers stay connected with the Chinese market, Match Plus, the fair’s online business matching platform, will support foreign buyers achieve their sourcing goals despite travel limitations. Further information on Match Plus will be available at a later stage.

The fair’s product categories cover 12 application areas, which comprehensively span a full range of potential uses in modern technical textiles and nonwovens. These categories also cover the entire industry, from upstream technology and raw materials providers to finished fabrics, chemicals and other solutions.

31.10.2022

BVMed: Medizintechnik-Branche fordert legislative Maßnahmen

Neue Zahlen der Europäische Kommission zur Implementierung der EU-Medizinprodukte-Verordnung (MDR) zeigen nach Ansicht des Bundesverbandes Medizintechnologie (BVMed) zwar Tendenzen in die richtige Richtung, „nach mehr als fünf Jahren der Umsetzung verfügt das MDR-Regulierungssystem aber immer noch nicht über ausreichende Zertifizierungskapazitäten“, so BVMed-Geschäftsführer und Vorstandsmitglied Dr. Marc-Pierre Möll. Die europäische Medizintechnik-Branche fordert daher in einem Schreiben an die EU-Kommission und Gesundheitsminister:innen der EU-Mitgliedsstaaten, zusätzlich zu den bisher durchgeführten untergesetzlichen Lösungen, „legislative Maßnahmen“ auf dem EPSCO-Meeting im Dezember 2022 zu beschließen. Dazu gehören die Verlängerung der Übergangsfristen nach einem risikobasierten Ansatz oder die Abschaffung der bestehenden Abverkaufsfrist.

Die EU-Kommission hat Ende Oktober 2022 unter anderem folgende aktuelle Zahlen zur MDR vorgestellt:

Neue Zahlen der Europäische Kommission zur Implementierung der EU-Medizinprodukte-Verordnung (MDR) zeigen nach Ansicht des Bundesverbandes Medizintechnologie (BVMed) zwar Tendenzen in die richtige Richtung, „nach mehr als fünf Jahren der Umsetzung verfügt das MDR-Regulierungssystem aber immer noch nicht über ausreichende Zertifizierungskapazitäten“, so BVMed-Geschäftsführer und Vorstandsmitglied Dr. Marc-Pierre Möll. Die europäische Medizintechnik-Branche fordert daher in einem Schreiben an die EU-Kommission und Gesundheitsminister:innen der EU-Mitgliedsstaaten, zusätzlich zu den bisher durchgeführten untergesetzlichen Lösungen, „legislative Maßnahmen“ auf dem EPSCO-Meeting im Dezember 2022 zu beschließen. Dazu gehören die Verlängerung der Übergangsfristen nach einem risikobasierten Ansatz oder die Abschaffung der bestehenden Abverkaufsfrist.

Die EU-Kommission hat Ende Oktober 2022 unter anderem folgende aktuelle Zahlen zur MDR vorgestellt:

  • Von 80 unter den alten Richtlinien designierten Benannten Stellen haben 62 Stellen MDR-Anträge gestellt.
  • Mittlerweile gibt es 34 Benannte Stellen unter der MDR.
  • Rund 23.000 Zertifikate müssen noch in die MDR überführt werden.
  • Über 75 Prozent (17.000) dieser Zertifikate laufen im Mai 2024 aus.
  • Bislang – Stand: Oktober 2022 – wurden 8.120 Anträge angenommen und 1.990 MDR-Zertifikate ausgestellt. Im April 2022 waren es 1.069 Zertifikate.
  • Die Bearbeitungszeit liegt bei keinem einzigen MDR-Zertifikat (QMS und Produktprüfung) unter einem Jahr. 82 Prozent der Zertifikate dauern zwischen 13 und 18 Monaten, 18 Prozent zwischen 19 und 24 Monaten.

„Die Zahlen zeigen, dass zwar seit April 2022 mehr Zertifikate ausgestellt wurden, die Kapazitäten aber weiterhin bei weitem nicht für die Gesamtheit der Zertifikate ausreichen werden, um negative Folgen für die Patient:innenversorgung und die Markteinführung von Innovationen zu verhindern“, so BVMed-Geschäftsführer Möll. In einem vom europäischen Dachverband MedTech Europe koordinierten Schreiben an die EU-Kommission und die Gesundheitsminister:innen der EU-Mitgliedsstaaten haben deshalb über 300 Verbände und Unternehmen der Medizintechnik-Branche kürzlich „dringenden Handlungsbedarf für den Gesetzgeber“ bei der Umsetzung der MDR angemahnt.

Der vom Bundesgesundheitsministerium (BMG) begonnene Dialogprozess und die Vorschläge der Medical Device Coordination Group (MDCG) auf EU-Ebene seien zwar gute Ansätze, aber es sind weitere Schritte notwendig. „Wenn nicht unverzüglich Maßnahmen ergriffen werden, steht Europa vor einem Szenario, in dem eine große Anzahl bestehender Medizinprodukte, auf die sich Patient:innen, Krankenhäuser und andere Gesundheitseinrichtungen verlassen, nicht rechtzeitig rezertifiziert werden und daher Gefahr laufen, dauerhaft vom Markt zu verschwinden“, heißt es in dem Schreiben. „Gleichzeitig verzögert sich die Zertifizierung neuer und verbesserter Produkte, was dazu führt, dass die Patient:innen erst mit Verzögerung von den Vorteilen der Innovation profitieren.“ Die anhaltende COVID-19-Pandemie und die Folgen des russischen Angriffskrieges gegen die Ukraine hätten diese Situation durch Unterbrechungen der Lieferketten, deutliche Erhöhung der Energiepreise und Probleme bei der Durchführung von Audits vor Ort sowie bei klinischen Prüfungen noch verschärft.

Zusätzlich zu untergesetzlichen Lösungen seien daher so bald wie möglich legislative Maßnahmen erforderlich, heißt es in dem Schreiben, das unter anderem an den deutschen Gesundheitsminister Prof. Dr. Karl Lauterbach ging. Die europäische Medizintechnik-Industrie fordert darin:

  1. Verlängerung der Gültigkeit der Richtlinienzertifikate (Richtlinie über Medizinprodukte und Richtlinie über aktive implantierbare medizinische Geräte), um Bestandsprodukte verkehrsfähig zu erhalten. Diese Verlängerungen sollten analog zur Änderung der Verordnung über In-vitro-Diagnostika im Januar 2022 anhand eines risikobasierten Ansatzes erfolgen, also mit unterschiedlichen Fristen je Risikoklasse der Produkte.
  2. Zertifikate unter Auflagen für Bestandsprodukte sowie wesentlich geänderten und neuen Produkten, um beispielsweise mehr Zeit für die Zusammenstellung weiterer Daten und Nachweise zu schaffen, die zur Erfüllung der MDR-Anforderungen erforderlich sind.
  3. Abschaffung der in Artikel 120 Absatz 4 der MDR festgelegten Abverkaufsfrist, um die Bereitstellung bereits in Verkehr gebrachter Medizinprodukte über das Enddatum Mai 2025 hinaus zu ermöglichen. Auf diese Weise lässt sich die unnötige Entsorgung oder der Rückruf von bereits in Verkehr gebrachten sicheren Medizinprodukte vermeiden.

„Wir müssen diese gesetzgeberischen Maßnahmen zügig umsetzen – und gleichzeitig daran arbeiten, die Rolle Europas als attraktive Region für Investitionen in medizintechnische Innovationen zu stärken“, so der Appell von BVMed-Geschäftsführer Dr. Marc-Pierre Möll.

Source:

BVMed | Bundesverband Medizintechnologie e.V.

25.10.2022

BVMed gründet eigenes wissenschaftliches Institut

Der Bundesverband Medizintechnologie (BVMed) hat ein wissenschaftliches Institut gegründet, das sich unter anderem der Versorgungs- und Gesundheitssystemforschung sowie methodischen Fragen der Nutzenbewertung und des Health Technology Assessments (HTA) von Medizinprodukten widmen wird. „Zielsetzung des Institutes ist die Aufbereitung und methodische Diskussion von Evidenz zur Stärkung und Sicherung der Patientenversorgung mit Medizinprodukten“, so die Leiterin des BVMed-Instituts, Anne Spranger, auf der Jahrespressekonferenz des deutschen Medizintechnik-Verbandes.

Das BVMed-Institut wird dazu mit den relevanten Institutionen, beispielsweise den wissenschaftlichen Instituten der Krankenkassen, anderen Forschungseinrichtungen und auch Fachgesellschaften in Dialog treten sowie eine Übersicht zu Datenquellen und -methoden erarbeiten. Dazu sind eigene Auswertungen und Publikationen geplant. Zu den weiteren Aufgaben gehört die Organisation von Informations- und Fortbildungsformaten und die Erstellung von Leitfäden.

Der Bundesverband Medizintechnologie (BVMed) hat ein wissenschaftliches Institut gegründet, das sich unter anderem der Versorgungs- und Gesundheitssystemforschung sowie methodischen Fragen der Nutzenbewertung und des Health Technology Assessments (HTA) von Medizinprodukten widmen wird. „Zielsetzung des Institutes ist die Aufbereitung und methodische Diskussion von Evidenz zur Stärkung und Sicherung der Patientenversorgung mit Medizinprodukten“, so die Leiterin des BVMed-Instituts, Anne Spranger, auf der Jahrespressekonferenz des deutschen Medizintechnik-Verbandes.

Das BVMed-Institut wird dazu mit den relevanten Institutionen, beispielsweise den wissenschaftlichen Instituten der Krankenkassen, anderen Forschungseinrichtungen und auch Fachgesellschaften in Dialog treten sowie eine Übersicht zu Datenquellen und -methoden erarbeiten. Dazu sind eigene Auswertungen und Publikationen geplant. Zu den weiteren Aufgaben gehört die Organisation von Informations- und Fortbildungsformaten und die Erstellung von Leitfäden.

Source:

BVMed | Bundesverband Medizintechnologie e.V.

(c) BVMed
21.10.2022

BVMed: „Kosten-Tsunami“ bei aufsaugenden Inkontinenzprodukten

Die im Bundesverband Medizintechnologie (BVMed) organisierten Hersteller von aufsaugenden Inkontinenzprodukten schlagen aufgrund explodierender Rohstoff-, Transport- und Energiepreise Alarm. Der steigende Preisdruck wird durch sinkende Monatspauschalen in den Hilfsmittel-Versorgungsverträgen mit Krankenkassen noch verstärkt. „Die Schere zwischen sinkenden Erstattungspreisen und steigenden Produktionskosten nimmt stetig zu. Dieser Kosten-Tsunami gefährdet die medizinische Versorgungsqualität der Betroffenen“, so BVMed-Expertin Juliane Pohl, Leiterin des Referats Ambulante Versorgung. Der BVMed sieht dringenden Handlungsbedarf, um die qualitätsgefährdenden Mechanismen der bestehenden Pauschalsystematik zu überwinden.

Die Bewältigung der COVID-19-Pandemie und der Ukraine-Krieg haben die Verfügbarkeit von Rohstoffen und Energie, die globalen Lieferketten sowie das Transportwesen stark beeinträchtigt. Diese Veränderungen führen zu immensen Preissteigerungen, die sich unmittelbar auf die Herstellung von Medizinprodukten auswirken – darunter die Produktion von Hilfsmitteln zur aufsaugenden Inkontinenzversorgung. Ein paar Beispiele zu den Auswirkungen:

Die im Bundesverband Medizintechnologie (BVMed) organisierten Hersteller von aufsaugenden Inkontinenzprodukten schlagen aufgrund explodierender Rohstoff-, Transport- und Energiepreise Alarm. Der steigende Preisdruck wird durch sinkende Monatspauschalen in den Hilfsmittel-Versorgungsverträgen mit Krankenkassen noch verstärkt. „Die Schere zwischen sinkenden Erstattungspreisen und steigenden Produktionskosten nimmt stetig zu. Dieser Kosten-Tsunami gefährdet die medizinische Versorgungsqualität der Betroffenen“, so BVMed-Expertin Juliane Pohl, Leiterin des Referats Ambulante Versorgung. Der BVMed sieht dringenden Handlungsbedarf, um die qualitätsgefährdenden Mechanismen der bestehenden Pauschalsystematik zu überwinden.

Die Bewältigung der COVID-19-Pandemie und der Ukraine-Krieg haben die Verfügbarkeit von Rohstoffen und Energie, die globalen Lieferketten sowie das Transportwesen stark beeinträchtigt. Diese Veränderungen führen zu immensen Preissteigerungen, die sich unmittelbar auf die Herstellung von Medizinprodukten auswirken – darunter die Produktion von Hilfsmitteln zur aufsaugenden Inkontinenzversorgung. Ein paar Beispiele zu den Auswirkungen:

  • Die Kosten für Superabsorber haben sich mehr als verdreifacht.
  • Die Kosten für Zellstoff, Polypropylen und Polyethylen haben sich mehr als verdoppelt.
  • Zusätzlich treibt die Verfünffachung der Energiepreise die Herstellkosten in ungeahnte Höhen.
  • Die nationalen und weltweiten Logistikkosten sind zudem aufgrund fehlender Transportkapazitäten und höherer Preise für Kraftstoffe, Verpackungen, Container und Paletten massiv gestiegen.

Zum Hintergrund der Versorgungsproblematik erläutert der BVMed, dass die Versorgung von Patient:innen mit Hilfsmitteln zur aufsaugenden Inkontinenzversorgung durch entsprechend qualifizierte Hilfsmittelleistungserbringer wie Sanitätshäuser oder Homecare-Versorger erfolgt. Diese vereinbaren mit Krankenkassen eine Erstattung für die monatliche Versorgung mit den Produkten sowie den dazu gehörigen Dienstleistungen wie die Auswahl des individuell erforderlichen Produkts, die Einweisung sowie die Unterstützung bei Komplikationen.

Das Problem: Die besondere Systematik bei der Vereinbarung dieser Erstattungsbeträge führt zu Vergütungen im sehr niedrigen zweistelligen Bereich. Die durchschnittliche Monatspauschale liegt aktuell bei unter 17 Euro für Versorgungen in der Häuslichkeit. Diese Pauschale umfasst alle individuell erforderlichen Produkte und Dienstleistungen sowie Logistik und sonstige Administration. Alle an der Versorgung Beteiligten seien nun aufgefordert, geeignete Antworten auf diese dramatischen Entwicklungen zu finden und Gegenmaßnahmen einzuleiten.

Source:

BVMed | Bundesverband Medizintechnologie e.V.

Photo: EREMA
21.10.2022

EREMA: Circular economy for PET fibres

The textile industry is the third largest consumer of plastics. While growth rates in the production of fibres and textiles are high, the circular economy has hardly become established in this segment. The EREMA Group is now intensifying development of recycling solutions for this application with their new fibres and textiles business unit. Currently, the focus is on PET fibre materials from fibre production and subsequent processing steps. Technologies for recycling mixed fibre textiles from textile collection sources are to follow in a follow-up project phase.

The textile industry is the third largest consumer of plastics. While growth rates in the production of fibres and textiles are high, the circular economy has hardly become established in this segment. The EREMA Group is now intensifying development of recycling solutions for this application with their new fibres and textiles business unit. Currently, the focus is on PET fibre materials from fibre production and subsequent processing steps. Technologies for recycling mixed fibre textiles from textile collection sources are to follow in a follow-up project phase.

"With EREMA's VACUREMA® and INTAREMA® technology and PURE LOOP's ISEC evo technology, our company group already has an extensive range of machines for fibre and PET recycling applications. For ecologically and economically sound recycling, however, new technological solutions are needed to use the recycled fibres in higher-value end applications and to achieve a functioning circular economy," explains Wolfgang Hermann, Business Development Manager Application Fibres & Textiles, EREMA Group GmbH. The initial focus will be on PET, regarded as a key material for the production of synthetic fibres. The aim is to find recycling solutions that allow PET fibre materials to be prepared for reuse in PET fibre production processes. This is a significant step for the circular economy because PET fibres in textiles account for about two-thirds of the total volume of PET.

In this development work, the EREMA Group can build on existing know-how. Proven recycling technologies have been combined with a new IV optimiser. "This extends the residence time of the PET melt, which is particularly necessary in fibre recycling to efficiently remove spinning oils. Our recycling process also increases the IV value of the PET melt after extrusion back to the specific level that is essential for production of the fibre," explains Hermann. Waste PET fibre from production processes can therefore be further processed into rPET filament fibre, carpet yarn and staple fibre.

Fibre test centre with plant to test customers' materials
In order to accelerate development work, EREMA opened its own fibre test centre a few months ago, where a cross-company team is working on recycling solutions for fibre-to-fibre applications.

Source:

EREMA Gruppe

(c) Carbios
20.10.2022

Carbios publishes results of consumer research study about plastic circularity

  • Carbios’ biorecycling and biodegradation technologies internationally recognized by consumers as promising answers to their top environmental concerns
  • Carbios’ innovations considered one of the best for solving recycling effectively and achieving a real plastic circularity
  • Consumer research including qualitative and quantitative fields was conducted between March and August 2022. The research institute, Strategic Research, conducted 6000 interviews in Europe and USA

Carbios’ biorecycling and biodegradation technologies acclaimed by consumers
During the first research field study, respondents were exposed to Carbios’ biorecycling process; a new enzyme-based biotechnology that enables biological recycling of all types of PET plastic waste (including bottles, packaging and textiles), and pushes the boundaries of recycling in terms of the number of cycles.

  • Carbios’ biorecycling and biodegradation technologies internationally recognized by consumers as promising answers to their top environmental concerns
  • Carbios’ innovations considered one of the best for solving recycling effectively and achieving a real plastic circularity
  • Consumer research including qualitative and quantitative fields was conducted between March and August 2022. The research institute, Strategic Research, conducted 6000 interviews in Europe and USA

Carbios’ biorecycling and biodegradation technologies acclaimed by consumers
During the first research field study, respondents were exposed to Carbios’ biorecycling process; a new enzyme-based biotechnology that enables biological recycling of all types of PET plastic waste (including bottles, packaging and textiles), and pushes the boundaries of recycling in terms of the number of cycles.

The research results demonstrated that European and US respondents find Carbios’ biorecycling technology more unique and innovative than traditional PET recycling (i.e. thermo-mechanical recycling), as well as more relevant in its ability to address their concerns and challenges regarding recycling.

In the second research study, conducted in the US, respondents were also exposed to Carbios’ biodegradation technology: an innovative enzymatic solution by which an enzyme is incorporated into plastics during the production process of bio-sourced PLA plastics (corn, sugar cane). This approach makes the material made from plants 100% compostable at ambient temperatures and degradable like plants with the built-in enzyme biologically breaking the bioplastic down in less than eight weeks without microplastics or toxic residues; creating a fully organic circularity.

Similarly to Carbios’ biorecycling technology, Carbios’ PLA biodegradation innovation caught US respondents’ attention with 64% overall liking it. Additionally, 93% of the respondents sampled described the concept as innovative, unique, easy to understand (49%), and believable (43%). Up to 82% of the most environmentally engaged respondents declared they would definitely buy more products made with Carbios’ fully circular biodegradable bioplastic.

Consumers: No other choice but to make plastic fully circular
The research says 99% of the respondents consider it important to protect the environment, while plastic pollution is now ranked the third most-concerning environmental issues after climate change and ocean pollution.

This awareness brings most of these consumers to be environmentally active when it comes to purchasing goods and sorting. For the US respondents, eco-friendly packaging comes in the fourth place in terms of purchase drivers for packaged goods and 65% of them declare sorting plastic from general waste on a regular basis, which makes plastic the most sorted type of waste.

Nevertheless, for a vast majority of the respondents across geographies, even if they would like to reduce their plastic consumption most of the time there is no suitable alternative that is as convenient, light, and cost-efficient as plastics. Hence in an ideal world, consumers would like all plastic waste in landfills and oceans to be collected, cleaned, reused and recycled.

More information:
Carbios study circularity plastics
Source:

Carbios

(c) CHT Germany GmbH
19.10.2022

CHT Group launches new brand for jeans and garment treatment

The ecological and social conditions in the production of textiles are coming to the fore and into the consciousness of industry and end customers. With the new LAB102 brand, the "Jeans & Garment" team of the CHT Group to offer its global denim customers sustainable chemical solutions and technologies in the future.

Where does the name "LAB102 - Blue veins of CHT" come from?
LAB was chosen not only because the English word for laboratory fits perfectly with a chemical company, but also because it stands for innovation, development, and discovery. The digits 102 in the name refer to the house number of CHT's corporate headquarters in Tübingen.
The slogan "Blue veins of CHT" maintains the connection to the name CHT which is well-known in the industry. Moreover, the denim or jeans industry is traditionally and historically indigo - thus blue.

The ecological and social conditions in the production of textiles are coming to the fore and into the consciousness of industry and end customers. With the new LAB102 brand, the "Jeans & Garment" team of the CHT Group to offer its global denim customers sustainable chemical solutions and technologies in the future.

Where does the name "LAB102 - Blue veins of CHT" come from?
LAB was chosen not only because the English word for laboratory fits perfectly with a chemical company, but also because it stands for innovation, development, and discovery. The digits 102 in the name refer to the house number of CHT's corporate headquarters in Tübingen.
The slogan "Blue veins of CHT" maintains the connection to the name CHT which is well-known in the industry. Moreover, the denim or jeans industry is traditionally and historically indigo - thus blue.

Focus on sustainability
LAB102 focuses not only on chemistry, but also on technology. Fogging, laser, and ozone technologies are innovations that currently enable new approaches in jeans and garment treatment and are at a high ecological level. Their use can lead to savings in water and energy. The use of chemicals can also be reduced if processes are optimized and adapted to the new requirements. To this end, the CHT Group's "Jeans & Garment" team works with the leading machine manufacturers on new developments.

Source:

CHT Germany GmbH

(c) Tonello
17.10.2022

Tonello presents Laundry (R)Evolution at Kingpins

Tonello will be unveiling the release of their new, more efficient and more responsible Laundry (R)Evolution, including three tools, at Kingpins Show in Amsterdam, from October 19-20.

Configurator
The new Configurator allows clients to choose the technologies, software, and accessories for their next laundry, combining diverse solutions and thus obtaining a real projection of energy and resource consumption, as well as savings and sustainability benefits.

B.O.P. (Be On Point)
The seamless integration with THE Laser, B.O.P. is based on the most recent developments in Computer Vision It makes positioning laser designs on garments automatic and rapid It allows a choice of different production modes and detects up to 8 garments at the same time.

Metro
Metro is a software that automatically and transparently measures the actual consumption of a laundry, summarizing these figures in each garment’s “environmental passport”.

Tonello will be unveiling the release of their new, more efficient and more responsible Laundry (R)Evolution, including three tools, at Kingpins Show in Amsterdam, from October 19-20.

Configurator
The new Configurator allows clients to choose the technologies, software, and accessories for their next laundry, combining diverse solutions and thus obtaining a real projection of energy and resource consumption, as well as savings and sustainability benefits.

B.O.P. (Be On Point)
The seamless integration with THE Laser, B.O.P. is based on the most recent developments in Computer Vision It makes positioning laser designs on garments automatic and rapid It allows a choice of different production modes and detects up to 8 garments at the same time.

Metro
Metro is a software that automatically and transparently measures the actual consumption of a laundry, summarizing these figures in each garment’s “environmental passport”.

At the show, Tonello will also demonstrate their technologies by washing the MSP Collection, in collaboration with PVH Europe, Kingpins, and designed by Piero Turk.

Source:

Tonello

(c) BVMed
13.10.2022

BVMed: Ergebnisse der Herbstumfrage 2022

Die Umsatzentwicklung der Medizintechnik-Branche zeigt sich nach den Ergebnissen der Herbstumfrage des Bundesverbandes Medizintechnologie (BVMed) mit einem prognostizierten Plus von 3,3 Prozent gegenüber dem Vorjahr leicht erholt. Die Gewinne der MedTech-Branche werden 2022 jedoch aufgrund der dramatischen Kostensteigerungen bei den Transport-, Rohstoff- und Energiepreisen sowie den regulatorischen Mehraufwand durch die EU-Medizinprodukte-Verordnung (MDR) insgesamt zurückgehen. Dennoch schaffen die Unternehmen neue Arbeitsplätze und investieren in Produktionsstandorte, so das Ergebnis der BVMed-Herbstumfrage, die BVMed-Geschäftsführer Dr. Marc-Pierre Möll auf der Jahrespressekonferenz des MedTech-Verbandes vorstellte.

Die Kostensteigerungen und bürokratischen Hemmnisse durch die MDR führen zudem zu einem Rückgang der Innovationsdynamik der Branche. Der Innovationsklima-Index der MedTech-Branche ist mit 3,6 auf einer Zehnerskala auf einem Tiefstwert. „Das zeigt die Dramatik der Herausforderungen für die KMU-geprägte MedTech-Branche in Deutschland auf“, so Möll. An der Herbstumfrage nahmen 120 Mitgliedsunternehmen des BVMed teil.

Die Umsatzentwicklung der Medizintechnik-Branche zeigt sich nach den Ergebnissen der Herbstumfrage des Bundesverbandes Medizintechnologie (BVMed) mit einem prognostizierten Plus von 3,3 Prozent gegenüber dem Vorjahr leicht erholt. Die Gewinne der MedTech-Branche werden 2022 jedoch aufgrund der dramatischen Kostensteigerungen bei den Transport-, Rohstoff- und Energiepreisen sowie den regulatorischen Mehraufwand durch die EU-Medizinprodukte-Verordnung (MDR) insgesamt zurückgehen. Dennoch schaffen die Unternehmen neue Arbeitsplätze und investieren in Produktionsstandorte, so das Ergebnis der BVMed-Herbstumfrage, die BVMed-Geschäftsführer Dr. Marc-Pierre Möll auf der Jahrespressekonferenz des MedTech-Verbandes vorstellte.

Die Kostensteigerungen und bürokratischen Hemmnisse durch die MDR führen zudem zu einem Rückgang der Innovationsdynamik der Branche. Der Innovationsklima-Index der MedTech-Branche ist mit 3,6 auf einer Zehnerskala auf einem Tiefstwert. „Das zeigt die Dramatik der Herausforderungen für die KMU-geprägte MedTech-Branche in Deutschland auf“, so Möll. An der Herbstumfrage nahmen 120 Mitgliedsunternehmen des BVMed teil.

Detaillierte Informationen zur Umfrage finden Sie hier.

Source:

BVMed | Bundesverband Medizintechnologie e.V.

(c) INDA
07.10.2022

INDA: Highlights of the 12th edition of RISE®

  • DiaperRecycle Wins RISE® Innovation Award for Technology that Transforms Used Diapers into Cat Litter

Product development and innovators in nonwovens & engineered materials gained expert insights on material science innovation and sustainability at the 12th edition of RISE® — Research, Innovation & Science for Engineered Fabrics conference, organized by INDA, the Association of the Nonwoven Fabrics Industry, and The Nonwovens Institute, North Carolina State University, Sept. 27-28 at North Carolina State University in Raleigh, NC.

More than 20 industry, academic, and government experts from across the globe presented technical developments in sessions focused on circularity and sustainable inputs from such sources as Polylactic Acid Polymers (PLA), natural fibers, biofibers, and waste products.

  • DiaperRecycle Wins RISE® Innovation Award for Technology that Transforms Used Diapers into Cat Litter

Product development and innovators in nonwovens & engineered materials gained expert insights on material science innovation and sustainability at the 12th edition of RISE® — Research, Innovation & Science for Engineered Fabrics conference, organized by INDA, the Association of the Nonwoven Fabrics Industry, and The Nonwovens Institute, North Carolina State University, Sept. 27-28 at North Carolina State University in Raleigh, NC.

More than 20 industry, academic, and government experts from across the globe presented technical developments in sessions focused on circularity and sustainable inputs from such sources as Polylactic Acid Polymers (PLA), natural fibers, biofibers, and waste products.

Highlights included presentations on Achieving Supply Chain Circularity, by Kat Knauer, Ph.D., Program Manager – V Research, National Renewable Energy Laboratory, NREL; The Global Plastic Crisis: Winners/Losers in the Marketplace, by Bryan Haynes, Ph.D., Senior Technical Director, Global Nonwovens, Kimberly-Clark Corporation; Sustainable Fibers – Development and the Future by Jason Locklin, Ph.D. Director, University of Georgia – New Materials Institute; PLA & PLA Blends: Practical Aspects of Extrusion by Behnam Pourdeyhimi, Ph.D., William A. Klopman Distinguished Professor, and Executive Director, The Nonwovens Institute, North Carolina State University; and Mitigation of Quat Incompatibility with Cotton and other Cellulosic-based Substrates, by Doug Hinchliffe, Ph.D., Research Molecular Biologist, USDA-ARS.

RISE® Innovation Award Winner
DiaperRecycle was awarded the RISE® Innovation Award for its innovative technology to recycle used diapers into absorbent and flushable cat litter. The annual award recognizes innovation in areas within and on the periphery of the nonwovens industry that use advanced science and engineering principles to develop unique or intricate solutions to problems and advance  nonwovens usage.

By diverting used diapers from households and institutions, and separating the plastic and fiber, DiaperRecycle strives to decrease the climate-changing emissions of diapers from landfills.  “I am thrilled and grateful to win this award — as it proves we are on the right track,” said Cynthia Wallis Barnicoat, CEO of DiaperRecycle.

Other award finalists included Binder BioHook® by Gottlieb Binder GmbH & Co. KG and Sero® hemp fibers from Bast Fibre Technologies, Inc. (BFT).

The 13th edition of RISE® — Research, Innovation & Science for Engineered Fabrics conference will be held Sept. 12-13, 2023 at North Carolina State University in Raleigh, NC.

Source:

INDA

07.10.2022

BVMed unterstützt GKV-Vorschlag zur Senkung der Mehrwertsteuer auf Arznei- und Hilfsmittel

Der Bundesverband Medizintechnologie (BVMed) unterstützt den Vorschlag des GKV-Spitzenverbandes, die Mehrwertsteuer auf Arznei- und Hilfsmittel einheitlich abzusenken.

Aufgrund der unterschiedlichen Besteuerung bei Medizinprodukten sei es notwendig, mit einem einheitlichen Steuersatz für Klarheit bei allen Beteiligten zu sorgen. Als Beispiele nannte der BVMed Herzschrittmacher und Elektroden, die unterschiedliche Mehrwertsteuersätze hätten. Für Hüft- und Knieimplantate gelte der ermäßigte Mehrwertsteuersatz nur bei Bestellung von kompletten gelenkbildenden Komponenten. Für einzelne Teile und Zubehör, wie beispielsweise einem Hüftkopf, zähle dagegen der volle Mehrwertsteuersatz. Auch bei Wirbelsäulenschraubensystemen gebe es in der Praxis immer wieder Abgrenzungs- und Definitionsprobleme. „Wir sollten die jetzige Diskussion nutzen, um hier endlich Klarheit und Rechtssicherheit zu schaffen“, so Möll.

Der Bundesverband Medizintechnologie (BVMed) unterstützt den Vorschlag des GKV-Spitzenverbandes, die Mehrwertsteuer auf Arznei- und Hilfsmittel einheitlich abzusenken.

Aufgrund der unterschiedlichen Besteuerung bei Medizinprodukten sei es notwendig, mit einem einheitlichen Steuersatz für Klarheit bei allen Beteiligten zu sorgen. Als Beispiele nannte der BVMed Herzschrittmacher und Elektroden, die unterschiedliche Mehrwertsteuersätze hätten. Für Hüft- und Knieimplantate gelte der ermäßigte Mehrwertsteuersatz nur bei Bestellung von kompletten gelenkbildenden Komponenten. Für einzelne Teile und Zubehör, wie beispielsweise einem Hüftkopf, zähle dagegen der volle Mehrwertsteuersatz. Auch bei Wirbelsäulenschraubensystemen gebe es in der Praxis immer wieder Abgrenzungs- und Definitionsprobleme. „Wir sollten die jetzige Diskussion nutzen, um hier endlich Klarheit und Rechtssicherheit zu schaffen“, so Möll.

Die BVMed-Expert:innen verweisen in diesem Zusammenhang auf die Änderung der EU-Mehrwertsteuerrichtlinie (Richtlinie [EU] 2022/542) vom April 2022, die bis spätestens Ende 2024 national umgesetzt werden muss. Die EU-Richtlinie eröffnet die Möglichkeit für einen ermäßigten Mehrwertsteuersatz nicht nur „für Arzneimittel, die für ärztliche und tierärztliche Zwecke verwendet werden, einschließlich der Erzeugnisse für Zwecke der Empfängnisverhütung und der Monatshygiene sowie absorbierende Hygieneprodukte“, sondern auch „für medizinische Geräte, Vorrichtungen, Produkte, Artikel, Hilfsmittel und Schutzausrüstung, einschließlich Atemschutzmasken, die üblicherweise für die Verwendung in der Gesundheitsversorgung oder für den Gebrauch von Behinderten bestimmt sind, Gegenstände die wesentlich sind um eine Behinderung auszugleichen oder zu bewältigen, sowie die Anpassung, Instandsetzung, Vermietung und Leasing solcher Gegenstände.“

„Die EU ermöglicht einen ermäßigten Mehrwertsteuersatz auf Arzneimittel und Medizinprodukte. Der Vorschlag ist sinnvoll, denn er entlastet die Krankenkassen und Krankenhäuser und sorgt für Klarheit und Rechtssicherheit bei den Herstellern. Ein einheitlicher Mehrwertsteuersatz muss endlich umgesetzt werden!“, so BVMed-Geschäftsführer Möll.

Source:

BVMed - Bundesverband Medizintechnologie e.V.

04.10.2022

Carbios appoints Pascal Bricout as Chief Strategy and Financial Officer

Carbios announced the appointment of Pascal Bricout as Chief Strategy and Financial Officer and a member of the Company’s Executive Committee.

Mr. Bricout will oversee the management and organization of Carbios’ Finance division. He will also steer the Group’s Strategy, investor relations and the launch of the company’s Corporate Social Responsibility policy. He joins the company with over 30 years’ experience in finance, strategy and international mergers and acquisitions.
 
Prior to joining Carbios, Mr. Bricout served as Chief Financial Officer for Michelin in Asia, which is a major area of growth and development for the company. Over the past 10 years, he has focused primarily on major strategic mergers and acquisitions.

Mr. Bricout holds a Master Degree in Finance from Université Paris-Dauphine. He began his career at PwC, as a manager in the International Transactions Services teams in Paris and London.

Carbios announced the appointment of Pascal Bricout as Chief Strategy and Financial Officer and a member of the Company’s Executive Committee.

Mr. Bricout will oversee the management and organization of Carbios’ Finance division. He will also steer the Group’s Strategy, investor relations and the launch of the company’s Corporate Social Responsibility policy. He joins the company with over 30 years’ experience in finance, strategy and international mergers and acquisitions.
 
Prior to joining Carbios, Mr. Bricout served as Chief Financial Officer for Michelin in Asia, which is a major area of growth and development for the company. Over the past 10 years, he has focused primarily on major strategic mergers and acquisitions.

Mr. Bricout holds a Master Degree in Finance from Université Paris-Dauphine. He began his career at PwC, as a manager in the International Transactions Services teams in Paris and London.

Mr. Bricout, Carbios’ Chief Strategy & Financial Officer noted: “I am thrilled to be joining Carbios and proud to take part in this concrete, meaningful advance toward circular economy. Having developed unparalleled breakthrough technologies in plastic and textile biodegradation and biorecycling, Carbios now needs to execute a successful industrial and commercial phase. This is crucial for companies using PET to achieve, from 2025, their sustainable development goals. Within this dynamic context, Carbios and its subsidiary, Carbiolice, are poised to become global leaders in the development and industrialization of innovative bioprocesses to revolutionize the life cycles of plastics and textiles.”

More information:
Carbios green chemistry polymer
Source:

Carbios